It has been postulated that under hyperglycemic conditions, AhR complexes with specific transcriptional factors, early growth response (EGR-1), and activator protein-2 (AP-2), that mediate changes in ECs gene expression, leading to endothelial dysfunction and other vascular diseases [72]. The gene discussed is TFAP2A; the disease is endothelial dysfunction.